Depression and anxiety are common comorbidities in breast cancer patients. Whether
depression and anxiety are associated with breast cancer progression or mortality is …

Abstract N6-methyladenosine (m6A), the most abundant internal modification of RNA in
eukaryotic cells, has gained increasing attention in recent years. The m6A modification …

Using pre-treatment gene expression, protein/phosphoprotein, and clinical data from the I-
SPY2 neoadjuvant platform trial (NCT01042379), we create alternative breast cancer …

Background: Cancer is one of the leading causes of death globally, but its burden is not
uniform. GLOBOCAN 2020 has newly updated the estimates of cancer burden. This study …

Background Breast cancer (BC) has been increasing globally, though it is unclear whether
the increases are seen across all age groups and regions and whether changes in rates can …

Abstract Background N6-methyladenosine (m6A) modification is the most pervasive
modification in mRNA, and has been considered as a new layer of epigenetic regulation on …

This study aimed to evaluate the global incidence and mortality trends of breast cancer
among females by region and age in the past decade. We retrieved country-specific …

Breast cancer is a common malignancy among women worldwide. Regardless of the
economic status of a country, breast cancer poses a burden in prevention, diagnosis and …

Breast cancer disease is recognized as one of the leading causes of death in women
worldwide after lung cancer. Breast cancer refers to a malignant neoplasm that develops …

N 6-methyladenosine (m6A) modification of mRNA plays a role in regulating embryonic stem
cell pluripotency. However, the physiological signals that determine the balance between …